Elaclox DCX (AUS)
ELACLOX DCX Dry Cow Intramammary Suspension is a
stable intramammary suspension prepared under sterile
conditions and contains 600 mg CLOXACILLIN (as the
benzathine salt) in a long acting base. Benzathine
cloxacillin is a semi-synthetic penicillin derived from
ELACLOX DCX is presented in syringes of 5.4 g for
intramammary infusion and is designed to be used in dairy
cows at the point of drying-o, that is immediately after
the last milking of the lactation.
ELACLOX DCX is highly eective against Streptococcus
agalactiae and other streptococcal species, penicillin
resistant and sensitive staphylococci, Arcanobacterium
pyogenes and other species susceptible to cloxacillin.
Unlike natural penicillins, cloxacillin is not destroyed by
beta lactamase. It is therefore active against penicillin
resistant Staphylococci which are an important cause of
mastitis. Eective antibiotic levels are maintained in the
udder of the dry cow for 7-8 weeks.
The antibiotic is bactericidal in action and is non-irritant in
the udder tissues.
ELACLOX DCX is recommended for the control of mastitis
in dairy cows caused by Streptococcus spp., Staphylococcus
spp., (including penicillin resistant strains), Arcanobacterium
spp. and other organisms susceptible to cloxacillin.
DIRECTIONS FOR USE
DO NOT USE in lactating cows or cows due to calve
within 35 days after treatment.
MILK: DO NOT USE in lactating cows or within 35
days of calving. After calving, colostrum or milk from
treated dry cows MUST NOT BE USED for human
consumption or processing for 96 hours (8 milkings).
If premature or unscheduled calving occurs, consult
the prescribing veterinarian for advice on handling
milk for bobby calves.
MEAT: DO NOT USE less than 30 days before
slaughter for human consumption.
EXPORT SLAUGHTER INTERVAL (ESI): This product
does not have an ESI established. For advice on the
ESI, contact the manufacturer on 1800 665 866
before using this product.
If ELACLOX DCX is accidentally administered to a lactating
animal or within 35 days of calving, contact the prescribing
veterinarian for advice.
This product is contraindicated for use in cows allergic to
Infuse the contents of one syringe per quarter immediately
after the nal milking of a lactation. Prior to infusing
ELACLOX DCX clean and disinfect the teat. Infuse one
syringe of ELACLOX DCX into each quarter then teat dip or
spray the teat. It is normally unnecessary and undesirable
to introduce further treatment during the dry period.
ELACLOX DCX is presented in syringes with a variable tip.
This variable tip allows for either full or partial insertion into
the teat orice. Partial insertion only is preferable, as it may
prevent unnecessary damage to the teat orice. Full
insertion will be needed for large teat orices.
There is evidence that partial insertion can reduce the
incidence of Staphylococcus aureus and Streptococcus uberis
infections (Boddie et. al., 1990)
Any variation by the prescribing veterinarian to the
approved dose, frequency, duration, route, disease
or target species may require extending the
approved withholding period.
Dispose of empty container by wrapping with paper and
putting in garbage.
If poisoning occurs, contact a doctor or Poisons
Information Centre. Phone Australia 131 126.
Store below 25ºC (Air conditioning). Protect from light.
APVMA Approval No: 51848